Eric Bjerkholt sold $728K of Mirum Pharmaceuticals (MIRM)

Executed Sep 12 2025, disclosed Sep 12 2025, the same day.

Value, as filed

$728K

9,578 sh × $76.01

Executed

Sep 12 2025

the trade date, as filed

Disclosed

Sep 12 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Eric Bjerkholt CHIEF FINANCIAL OFFICER profile →

Eric Bjerkholt (CHIEF FINANCIAL OFFICER) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $978K of MIRM (9,943 sh × $98.37, as filed), executed Sep 14.

The name

MIRM

Mirum Pharmaceuticals, Inc. MIRM · Healthcare · 60 filings in 24 months ticker →

Healthcare · Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitat…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Eric Bjerkholt in MIRM

MIRMSALE Mirum Pharmaceuticals, Inc. $978K
9,943 sh × $98.37
Exec Sep 14
Filed Sep 15 · 4:10 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $600K
6,001 sh × $99.90
Exec Aug 11
Filed Aug 12 · 5:14 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $508K
4,172 sh across 2 lots
Exec Jul 6
Filed Jul 8 · 5:07 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $469K
5,000 sh across 3 lots
Exec Jun 8
Filed Jun 9 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $670K
7,287 sh × $91.98
Exec Mar 16
Filed Mar 17 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $101K
1,053 sh × $96.19
Exec Jan 26
Filed Jan 27 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $133K
1,421 sh × $93.33
Exec Jan 22
Filed Jan 23 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $527K
as filed
Exec Aug 11 2025
Filed Aug 12 2025 · 5:30 PM ET